Switching Coating Additive Suppliers: A Practical Migration Guide
A structured process for evaluating and switching to alternative coating additive suppliers.

Why Formulators Switch — And Why They Hesitate
Every formulator has considered switching additive suppliers. The reasons are clear:
- Cost reduction: 15–30% savings on additive costs without changing performance
- Supply security: Reduce dependency on a single supplier
- Technical improvement: Access to newer technology or better support
- Local availability: Faster delivery, local technical service, easier logistics
But the hesitation is real:
- "What if performance drops?"
- "What if we get customer complaints?"
- "Re-qualifying takes time we don't have"
- "The current product works — why risk it?"
This guide provides a structured approach to switching that minimizes risk and maximizes the probability of a successful transition.
Step 1: Audit Your Current Additive Portfolio
Before switching anything, map what you're using:
| Additive Function | Current Product | Dosage | Cost/kg | Annual Volume | Annual Spend |
|---|---|---|---|---|---|
| Dispersant | |||||
| Defoamer | |||||
| Rheology modifier | |||||
| Wetting agent | |||||
| Leveling agent | |||||
| Adhesion promoter |
Prioritize by impact:
1. High volume, high cost — switch first (biggest savings)
2. High volume, low cost — switch second (volume savings)
3. Low volume, high cost — switch third (per-unit savings)
4. Low volume, low cost — switch last (minimal impact)
Step 2: Identify Comparable Alternatives
Use the competitor analogue mapping from your potential new supplier. ASTRA Chemical provides direct comparisons:
| Current Product | ASTRA Alternative | Function |
|---|---|---|
| DISPERBYK-103 | ASTRA DISP-1306 | Dispersant, water-based |
| DISPERBYK-190 | ASTRA DISP-1190 | Dispersant, universal |
| BYK-051 | ASTRA DF-1051 | Defoamer, silicone |
| BYK-024 | ASTRA DF-1024 | Defoamer, water-based |
| BYK-333 | ASTRA F-5001 | Slip additive |
| BYK-349 | ASTRA WA-1005 | Wetting agent |
| BYK-306 | ASTRA LA-2001 | Leveling agent |
| TEGO Dispers 750W | ASTRA DISP-1750 | Dispersant, water-based |
| TEGO Foamex 810 | ASTRA DF-1810 | Defoamer, silicone |
| TEGO Wet 270 | ASTRA WA-1001 | Wetting agent |
| TEGO Flow 300 | ASTRA LA-2005 | Leveling agent |
| Rheolate 350 | ASTRA REO-1350 | Rheology modifier, HEUR |
> Trademark notice: DISPERBYK, BYK, TEGO, Rheolate, and all other product names and trademarks mentioned in this article are the property of their respective owners. Their use in this article is for identification purposes only and does not imply any affiliation, endorsement, or sponsorship. ASTRA Chemical products are independently developed and manufactured. Product comparisons are based on ASTRA's laboratory testing and publicly available technical data.
>
> Important: "Comparable to" means similar chemistry and intended application range — it does not mean identical performance in all systems. Always conduct your own testing.
Step 3: Laboratory Screening (1–2 Weeks)
Test Protocol
For each additive you're switching:
A. Direct replacement test:
- Replace the current additive 1:1 by weight with the ASTRA alternative
- Use the same dosage as the current product
- Produce 1 kg lab batch
- Test: viscosity, grind quality (Hegman), gloss, color, defoaming, leveling
B. Dosage optimization:
- If 1:1 replacement is not optimal, adjust dosage ±20%
- Some alternatives are more efficient and work at lower dosage
- Record the optimal dosage for each product
C. Compatibility check:
- Test with the full formulation (all other additives present)
- Check for: haze, gelation, color shift, foam increase
- If incompatibility appears, adjust the addition order or try a different product variant
Decision Criteria
| Result | Action |
|---|---|
| Equal or better performance at same dosage | Proceed to Step 4 |
| Equal or better at lower dosage | Proceed to Step 4 (note savings) |
| Slightly worse, adjustable with dosage | Optimize and retest |
| Significantly worse or incompatible | Try different product variant |
Step 4: Production Trial (1 Week)
Preparation
- Produce a 100–500 kg production batch with the new additive
- Run on standard production equipment
- Have the current formulation batch as a control
What to Monitor
| Parameter | Method | Acceptable Range |
|---|---|---|
| Grind quality | Hegman gauge | Same or better than control |
| Viscosity | Brookfield, 2 speeds | ±15% of control |
| Application properties | Spray/roller/curtain per standard | Same as control |
| Dry film appearance | Visual, gloss meter | Same as control |
| Defects (foam, craters) | Visual inspection | Same or fewer than control |
| Dry time | BK recorder | ±10% of control |
Critical Success Factor
Run the production trial on a standard, well-understood formulation — not on a new or problematic product. This isolates the additive change from other variables.
Step 5: Customer Qualification (2–4 Weeks)
For Internal-Use Coatings (OEM, in-house)
- Run the new formulation through your standard QC protocol
- If all tests pass, switch. No external approval needed.
For Sold Coatings (Customer-facing)
- Option A (Low risk): Switch without customer notification if performance is equivalent and no specification change is needed
- Option B (Medium risk): Inform key customers of the change, provide test data, offer parallel samples
- Option C (High risk): For customers with written specifications naming specific additive brands — request specification change with supporting data
Tip: Most coating specifications specify performance (gloss, hardness, adhesion), not additive brands. Check the actual specification before assuming you need customer approval.
Step 6: Full Switch and Monitor
Implementation
- Switch all new production to the new additive
- Keep 1–2 batches of the old formulation as a safety buffer
- Monitor the first 10 production batches closely
Ongoing Monitoring (3 months)
- Track: defect rate, customer complaints, production efficiency, cost per kg
- Compare to the 3-month period before the switch
- Document savings and any performance differences
Cost Savings Example
Switching dispersant in a water-based architectural coating:
| Parameter | Current Product | ASTRA Alternative |
|---|---|---|
| Product | DISPERBYK-190 | ASTRA DISP-1190 |
| Dosage | 1.0% on pigment | 0.8% on pigment |
| Relative cost per kg | Baseline | Typically 25–40% lower |
| Formulation cost/kg (dispersant only) | Baseline | ~25–40% savings |
| Estimated annual savings (500,000 kg) | — | $25,000–50,000/year |
*Actual savings depend on your current pricing, volume, and system requirements. Contact ASTRA Chemical for a personalized cost comparison.*
This is for ONE additive in ONE formulation. A full portfolio switch typically saves 15–25% on total additive costs.
Common Concerns Addressed
"What if quality drops?"
That's what the lab screening and production trial are for. If the alternative doesn't match, don't switch that product. Switch the ones that pass.
"What if customers notice?"
If the coating meets the same specifications, customers won't notice. They buy performance, not additive brand names.
"What about technical support?"
ASTRA Chemical provides full technical support including laboratory testing, formulation assistance, and on-site trials. [Contact our technical team](/contact).
"Isn't re-qualification expensive?"
Yes, it costs time and lab resources. But a one-time qualification cost is quickly recovered through ongoing savings. Typical payback: 2–4 months.
Key Takeaways
- Switching additive suppliers is a structured process, not a gamble
- Start with high-volume, high-cost products for maximum savings impact
- Always test 1:1 replacement first, then optimize dosage
- Run production trials on standard formulations, not problematic ones
- Most specifications define performance, not additive brands — check before assuming you need customer approval
- A full portfolio switch typically saves 15–25% on additive costs with payback in 2–4 months
Testing additives for this application?
Send us your current formulation challenge and our technical team will recommend an ASTRA product package for lab screening.